Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 4/20 | 0.33 |
| ▸ | KLK1 | P06870 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butanedione SCHEMBL17913120 | 0.93 | CA1 (0.53) | CA1CA2CA12CA9ALOX15 | |
| Bicarbonate SCHEMBL4899567 | 0.91 | CA1 (0.55) | CA1CA2CA12CA9ALOX15 | |
| SCHEMBL672097 | 0.91 | CA1 (0.58) | CA1CA2CA12CA9ALOX15 | |
| Hydrochloric Acid SCHEMBL1242368 | 0.90 | CA1 (0.56) | CA1CA2CA12CA9ALOX15 | |
| Sulfuric Acid SCHEMBL2396292 | 0.85 | CA1 (0.51) | CA1CA2CA12CA9ALOX15 | |
| SCHEMBL19152428 | 0.80 | CA1 (0.42) | CA1CA2CA12CA9ALOX15 | |
| Malic Acid SCHEMBL31238937 | 0.79 | CA12 (0.43) | CA1CA2CA12CA9ALOX15 | |
| Creatine SCHEMBL28387242 | 0.78 | NOS3 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL449031 | 0.78 | NOS3 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL4098848 | 0.77 | CA1 (0.42) | CA1CA2CA12CA9NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080254198-A1 | Method of Preparing Creatine Ester Salts and Uses Thereof | BIO-ENGINEERED SUPPLEMENTS & NUTRITION, INC. (US) | 2008-10-16 | — | — | US | claimed |
| US-20080254198-A1 | Method of Preparing Creatine Ester Salts and Uses Thereof | BIO-ENGINEERED SUPPLEMENTS & NUTRITION, INC. (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080103202-A1 | METHOD OF PREPARING CREATINE ESTER SALTS AND USES THEREOF. | Ferguson, Chris (US) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103202-A1 | METHOD OF PREPARING CREATINE ESTER SALTS AND USES THEREOF. | LIPA, CETP, CKMT1A; CKMT1B | CA1 4026/4885CA2 2314/4885CA12 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.